Optiver Holding
KYMR icon

Optiver Holding’s Kymera Therapeutics KYMR Stock Holding History

Optiver Holding’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3K Sell
208
-28
-12% -$2.22K ﹤0.01% 1125
2025
Q4 		$18.4K Sell
236
-86
-27% -$5.81K ﹤0.01% 1039
2025
Q3 		$18.2K Buy
+322
New +$14.5K ﹤0.01% 996

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Optiver Holding's KYMR Position: Q1 2026 in Review

Optiver Holding reduced its Kymera Therapeutics (KYMR) stake by 12% in Q1 2026, selling an estimated $2.22K and leaving 208 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Optiver Holding first reported a position in KYMR in Q3 2025 and has held it in 3 quarters since. The position peaked at $18.4K in Q4 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Optiver Holding held 208 shares of Kymera Therapeutics worth $17.3K as of Q1 2026.
  • Optiver Holding sold 28 Kymera Therapeutics shares in Q1 2026, an estimated $2.22K.
  • Kymera Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1125 holding.
  • Optiver Holding first reported a position in Kymera Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Kymera Therapeutics position peaked at $18.4K in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.